FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Muzahir Tayebjee

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Extracellular Matrix

Procedures

Physiology

Platelet Activation

Co-author Network

Publications

TOP 3
Saagar Mahida; Campbell Cowan; Lee N Graham; Andrew J Hogarth; Muzahir H Tayebjee; Christopher B Pepper
Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.
Emma Lowe; Jyoshna Pratty; Muzahir H Tayebjee; Jonathan A T Sandoe
Survey of antibiotic prophylaxis for implantable cardiac electronic device (ICED) insertion in England.
Ross J Hunter; Laura Richmond; Ihab Diab; Mark J Earley; Simon C Sporton; Muzahir H Tayebjee; Richard J Schilling
Characterization of fractionated atrial electrograms critical for maintenance of atrial fibrillation: a randomized, controlled trial of ablation strategies (the CFAE AF trial).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Muzahir Tayebjee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Saagar Mahida; Campbell Cowan; Lee N Graham; Andrew J Hogarth; Muzahir H Tayebjee; Christopher B Pepper
Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2013;37(1):9-19.
2012: Emma Lowe; Jyoshna Pratty; Muzahir H Tayebjee; Jonathan A T Sandoe
Survey of antibiotic prophylaxis for implantable cardiac electronic device (ICED) insertion in England.
International journal of cardiology 2012;157(2):286-7.
2011: Ross J Hunter; Laura Richmond; Ihab Diab; Mark J Earley; Simon C Sporton; Muzahir H Tayebjee; Richard J Schilling
Characterization of fractionated atrial electrograms critical for maintenance of atrial fibrillation: a randomized, controlled trial of ablation strategies (the CFAE AF trial).
Circulation. Arrhythmia and electrophysiology 2011;4(5):622-9.
2011: Muzahir H Tayebjee; Simon C Sporton; Victoria Baker; Antonio Creta; Edward Duncan; Mark J Earley; Ross J Hunter; Richard J Schilling
Pulmonary vein isolation with radiofrequency ablation followed by cryotherapy: a novel strategy to improve clinical outcomes following catheter ablation of paroxysmal atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(9):1250-5.
2011: Refai Showkathali; Muzahir H Tayebjee; Julia Grapsa; Maysaa Alzetani; Petros Nihoyannopoulos; Luke S Howard; David C Lefroy; J Simon R Gibbs
Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension.
International journal of cardiology 2011;149(2):279-80.
2010: Rina Ariga; Muzahir H Tayebjee; Anne Benfield; Michelle Todd; David C Lefroy
Greater three-dimensional ventricular lead tip separation is associated with improved outcome after cardiac resynchronization therapy.
Pacing and clinical electrophysiology : PACE 2010;33(12):1490-6.
2010: Ross J Hunter; Matthew Ginks; Richard Ang; Ihab Diab; Farai C Goromonzi; Stephen Page; Victoria Baker; Laura Richmond; Muzahir H Tayebjee; Simon C Sporton; Mark J Earley; Richard J Schilling
Impact of variant pulmonary vein anatomy and image integration on long-term outcome after catheter ablation for atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(12):1691-7.
2010: Muzahir H Tayebjee; Antonio Creta; Stefan Moder; Ross J Hunter; Mark J Earley; Mehul B Dhinoja; Richard J Schilling
Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(11):1537-42.
2008: Hoong Sern Lim; Muzahir H Tayebjee; Kiat T Tan; Jeetesh Patel; Robert J MacFadyen; Gregory Y H Lip
Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
Thrombosis research 2008;122(3):307-13.
2007: Jaymin S Shah; derralynn hughes; Muzahir H Tayebjee; Robert J MacFadyen; Atul B Mehta; Perry M Elliott
Extracellular matrix turnover and disease severity in Anderson-Fabry disease.
Journal of inherited metabolic disease 2007;30(1):88-95.
2007: Deepak Goyal; Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients.
International journal of cardiology 2007;114(2):261-4.
2006: Sunil Nadar; Muzahir H Tayebjee; Franz Messerli; Gregory Y H Lip
Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Current pharmaceutical design 2006;12(13):1581-92.
2006: Muzahir H Tayebjee; Gregory Y H Lip; Kiat T Tan; Robert J MacFadyen
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.
Thrombosis and haemostasis 2006;95(1):202-4.
2006: Jeetesh Patel; Hoong Sern Lim; Sunil Nadar; Muzahir H Tayebjee; Elizabeth A Hughes; Gregory Yh Lip
Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.
Journal of hypertension 2006;24(1):117-21.
2005: Kiat T Tan; Muzahir H Tayebjee; Hoong Sern Lim; G Y H Lip
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(12):1657-62.
2005: Muzahir H Tayebjee; G Y H Lip; Robert J MacFadyen
What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?
Diabetic medicine : a journal of the British Diabetic Association 2005;22(12):1628-35.
2005: H S Lim; Muzahir H Tayebjee; K T Tan; Jeetesh Patel; R J Macfadyen; G Y H Lip
Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity.
Heart (British Cardiac Society) 2005;91(12):1605-6.
2005: Muzahir H Tayebjee; G Y H Lip; Robert J MacFadyen
Is there an association between hypertension and the development of coronary collateral flow?
Journal of human hypertension 2005;19(10):757-9.
2005: Kiat T Tan; Muzahir H Tayebjee; Robert J MacFadyen; Gregory Y H Lip; Andrew D Blann
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Platelets 2005;16(6):368-71.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Kiat T Tan; Jeetesh Patel; Elizabeth A Hughes; Robert J MacFadyen
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
The American journal of cardiology 2005;96(3):339-45.
2005: Kiat T Tan; Muzahir H Tayebjee; Robert J MacFadyen; Gregory Y H Lip
Relation of platelet activation to coronary angiographic severity and collateralization.
The American journal of cardiology 2005;96(2):208-10.
2005: Muzahir H Tayebjee; Gregory Y H Lip
Heterotopic heart transplantation.
International journal of cardiology 2005;101(2):311-2.
2005: Muzahir H Tayebjee; Ioannis Karalis; Sunil Nadar; D Gareth Beevers; Robert J MacFadyen; Gregory Y H Lip
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
American journal of hypertension 2005;18(3):325-9.
2005: Andrew D Blann; Kiat T Tan; Muzahir H Tayebjee; Indran Davagnanam; Mark Moss; Gregory Y H Lip
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Thrombosis and haemostasis 2005;93(3):578-83.
2005: Kaeng W Lee; Gregory Y H Lip; Muzahir H Tayebjee; William Foster; Andrew D Blann
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.
Blood 2005;105(2):526-32.
2005: Kiat T Tan; Muzahir H Tayebjee; Cheryl Lynd; Andrew D Blann; Gregory Y H Lip
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Annals of medicine 2005;37(1):61-6.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.
Current medicinal chemistry 2005;12(8):917-25.
2005: Muzahir H Tayebjee; H S Lim; Sunil Nadar; Robert J MacFadyen; G Y H Lip
Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
European journal of clinical investigation 2005;35(1):8-12.
2005: Muzahir H Tayebjee; Gregory Y H Lip; Andrew D Blann; Robert J MacFadyen
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Thrombosis research 2005;115(3):205-10.
2005: Muzahir H Tayebjee; Kiat T Tan; Robert J MacFadyen; G Y H Lip
Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.
Journal of internal medicine 2005;257(1):110-6.
2004: Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
The unifying role of matrix metalloproteinases in atheroma and vascular stroke.
Stroke; a journal of cerebral circulation 2004;35(10):2239.
2004: Muzahir H Tayebjee; Sunil Nadar; Robert J MacFadyen; Gregory Y H Lip
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
American journal of hypertension 2004;17(9):770-4.
2004: Muzahir H Tayebjee; Sunil Nadar; Andrew D Blann; D Gareth Beevers; Robert J MacFadyen; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
American journal of hypertension 2004;17(9):764-9.
2004: Muzahir H Tayebjee; H Sern Lim; Robert J MacFadyen; Gregory Y H Lip
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.
Diabetes care 2004;27(8):2049-51.
2004: Muzahir H Tayebjee; S P Singh; G Y H Lip
Autonomic reflexes in heterotopic heart transplantation.
International journal of clinical practice 2004;58(5):520-2.
2004: Muzahir H Tayebjee; G Y H Lip; Robert J MacFadyen
Collateralization and the response to obstruction of epicardial coronary arteries.
QJM : monthly journal of the Association of Physicians 2004;97(5):259-72.
2003: Fernando Alfonso; Muzahir H Tayebjee; Gregory Y H Lip
Restenosis after coronary stenting: the 'gender paradox'.
European heart journal 2003;24(24):2239.
2003: Muzahir H Tayebjee; Robert J MacFadyen; Gregory Y Lip
Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension?
Journal of hypertension 2003;21(12):2211-8.
2003: Muzahir H Tayebjee; Gregory Y H Lip
Psychosocial functioning of adults with congenital heart disease: a neglected area.
European heart journal 2003;24(23):2159; author reply 2159-60.
2003: Muzahir H Tayebjee; Gregory Y H Lip
Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus?
The American journal of cardiology 2003;92(1):47-9.
2003: Muzahir H Tayebjee; Kaeng W Lee; Gregory Y Lip
Salt-loading and nitric oxide inhibition after the menopause.
Journal of hypertension 2003;21(7):1255-7.
2003: Ali Hamaad; Muzahir H Tayebjee; Gregory Y H Lip
The METHRO trials.
Expert opinion on investigational drugs 2003;12(5):865-70.
2003: G Y H Lip; Deirdre Lane; TA Millane; Muzahir H Tayebjee
Psychological interventions for depression in adolescent and adult congenital heart disease.
Cochrane database of systematic reviews (Online) 2003;(3):CD004394.
2002: Muzahir H Tayebjee; Gregory Y Lip
Endothelin binding and calcium signalling in hypertension.
Journal of hypertension 2002;20(9):1711-2.